I am targeting bcl2 and bax pathway in breast cancer cells, MCF7 and MDAMb231 and my drug may block this pathway. According to my hypothesis, I will use western blot and qRT-PCR to confirm this effect. Should I use a positive control to study its effect in this pathway? if yes, which positive control I should select?

Similar questions and discussions